Jens Bollerslev
- Professor, consultant; DMSC, MD
- +47 230 71923
Publications 2022
Changes in maternal cortisol, cortisol binding globulin and cortisone levels following diagnosis of fetal anomaly
Psychoneuroendocrinology, 135, 105574
DOI 10.1016/j.psyneuen.2021.105574
Publications 2021
Cardiovascular consequences of parathyroid disorders in adults
Ann Endocrinol., 82 (3-4), 151-157
DOI 10.1016/j.ando.2020.02.003
Cerebrospinal fluid catecholamines in delirium and dementia
Brain Commun., 3 (3), fcab121
DOI 10.1093/braincomms/fcab121
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
J. Endocr. Soc., 5 (3), bvaa205
DOI 10.1210/jendso/bvaa205
Assessing Periprosthetic Bone in Total Wrist Arthroplasty: The Validity of DXA
J. Clin. Densitom., 24 (3), 433-441
DOI 10.1016/j.jocd.2020.10.006
Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial
Nutrients, 13 (7), 2361
DOI 10.3390/nu13072361
Development of the Bone Phenotype and microRNA Profile in Adults With Low-Density Lipoprotein Receptor-Related Protein 5-High Bone Mass (LRP5-HBM) Disease
JBMR Plus, 5 (9), e10534
DOI 10.1002/jbm4.10534
Dysregulated non-coding telomerase RNA component and associated exonuclease XRN1 in leucocytes from women developing preeclampsia-possible link to enhanced senescence
Sci Rep, 11 (1), 19735
DOI 10.1038/s41598-021-99140-z
Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study
Pediatr. Rheumatol., 19 (1), 56
DOI 10.1186/s12969-021-00543-z
Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study)
J. Bone Miner. Res., 36 (1), 3-11
DOI 10.1002/jbmr.4199
TGFBR3L-An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Cancers, 13 (1), 114
DOI 10.3390/cancers13010114
Effect of high-intensity training on bone health and body composition in lung transplant recipients: A secondary analysis of a randomized controlled trial
Clin. Transplant., 35 (8), e14375
DOI 10.1111/ctr.14375
Publications 2020
Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas
Cancers, 12 (10), 2980
DOI 10.3390/cancers12102980
ENDOCRINOLOGY IN THE TIME OF COVID-19 Management of calcium metabolic disorders and osteoporosis
Eur. J. Endocrinol., 183 (2), G57-G65
DOI 10.1530/EJE-20-0385
Consensus statement from 2(nd) International Conference on Controversies in Vitamin D
Rev. Endocr. Metab. Disord., 21 (1), 89-116
DOI 10.1007/s11154-019-09532-w
Multidisciplinary management of acromegaly: A consensus
Rev. Endocr. Metab. Disord., 21 (4), 667-678
DOI 10.1007/s11154-020-09588-z
Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma
Acta Neurochir., 162 (4), 845-852
DOI 10.1007/s00701-019-04068-z
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors
J. Clin. Endocrinol. Metab., 105 (8), 2587-2594
DOI 10.1210/clinem/dgaa281
Bone mineral density and vitamin D in paediatric intestinal failure patients receiving home parenteral nutrition
Clin. Nutr. ESPEN, 39, 234-241
DOI 10.1016/j.clnesp.2020.06.006
Invited Review: Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint
Neuropathol. Appl. Neurobiol., 46 (2), 89-110
DOI 10.1111/nan.12568
Changes in maternal blood glucose and lipid concentrations during pregnancy differ by maternal body mass index and are related to birthweight: A prospective, longitudinal study of healthy pregnancies
PLoS One, 15 (6), e0232749
DOI 10.1371/journal.pone.0232749
Content and system development of a digital patient-provider communication tool to support shared decision making in chronic health care: InvolveMe
BMC Med. Inform. Decis. Mak., 20 (1), 46
DOI 10.1186/s12911-020-1065-8
Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey
Clin. Endocrinol., 92 (2), 159-168
DOI 10.1111/cen.14128
Elevated levels of the secreted wingless agonist R-spondin 3 in preeclamptic pregnancies
J. Hypertens., 38 (7), 1347-1354
DOI 10.1097/HJH.0000000000002362
Elevated Cholesteryl Ester Transfer Protein Activity Early in Pregnancy Predicts Prediabetes 5 Years Later
J. Clin. Endocrinol. Metab., 105 (3), 854-865
DOI 10.1210/clinem/dgz119
Publications 2019
The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy
Int. J. Pediatr. Endocrinol., 2019 (1), 4
DOI 10.1186/s13633-019-0070-0
Is there a need for an emergency card in hypoparathyroidism?
J. Intern. Med., 285 (4), 429-435
DOI 10.1111/joim.12865
Individualised management of acromegaly
Eur. J. Endocrinol., 181 (2), R57-R71
DOI 10.1530/EJE-19-0124
Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)
Eur. J. Endocrinol., 181 (3), P1-P19
DOI 10.1530/EJE-19-0316
Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children
Mol. Nutr. Food Res., 63 (7), 1800990
DOI 10.1002/mnfr.201800990
Progressive loss of bone mass in children with Fontan circulation
Congenit. Heart Dis., 14 (6), 996-1004
DOI 10.1111/chd.12848
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
Diabetes Care, 42 (6), 1067-1074
DOI 10.2337/dc19-0093
Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus
Eur. J. Endocrinol., 180 (3), P1-P22
DOI 10.1530/EJE-18-0609
Association Between Abdominal Aortic Calcification, Bone Mineral Density, and Fracture in Older Women
J. Bone Miner. Res., 34 (11), 2052-2060
DOI 10.1002/jbmr.3830
Are volume measurements of non-functioning pituitary adenomas reliable?
Endocrine, 63 (1), 171-176
DOI 10.1007/s12020-018-1752-8
Physical Fitness in Patients With Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis Diagnosed in the Era of Biologics: A Controlled Cross-Sectional Study
Arthritis Care Res., 71 (12), 1611-1620
DOI 10.1002/acr.23818
Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with Cushing's syndrome in remission
Eur. J. Endocrinol., 180 (5), 329-338
DOI 10.1530/EJE-19-0028
Adipokines and macrophage markers during pregnancy-Possible role for sCD163 in prediction and progression of gestational diabetes mellitus
Diabetes-Metab. Res. Rev., 35 (3), e3114
DOI 10.1002/dmrr.3114
Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
Int. J. Mol. Sci., 20 (12), 2896
DOI 10.3390/ijms20122896
High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry
Eur. J. Endocrinol., 181 (5), 461-472
DOI 10.1530/EJE-19-0464
Publications 2018
Parathyroid hormone independent hypercalcemia in adults
Best Pract. Res. Clin. Endoc. Metab., 32 (5), 621-638
DOI 10.1016/j.beem.2018.06.005
Immunohistochemistry for transcription factor T-Pit as a tool in diagnostics of corticotroph pituitary tumours
Pituitary, 21 (4), 443
DOI 10.1007/s11102-018-0879-1
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Eur. J. Endocrinol., 178 (1), 65-74
DOI 10.1530/EJE-17-0546
Gene expression profiling of fast- and slow-growing non-functioning gonadotroph pituitary adenomas
Eur. J. Endocrinol., 178 (3), 295-307
DOI 10.1530/EJE-17-0702
The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism
Endocr. Connect., 7 (8), 941-948
DOI 10.1530/EC-18-0259
Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks' Gestation
Sci Rep, 8, 13392
DOI 10.1038/s41598-018-31614-z
The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours
Endocrine, 62 (2), 351-360
DOI 10.1007/s12020-018-1679-0
Leif Mosekilde IN MEMORIAM
J. Bone Miner. Res., 33 (11), 1913
DOI 10.1002/jbmr.3588
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D
Br. J. Clin. Pharmacol., 84 (10), 2194-2207
DOI 10.1111/bcp.13652
Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
Clin. Transplant., 32 (8), e13341
DOI 10.1111/ctr.13341
Vitamin D and Primary Hyperparathyroidism
Front.Horm.Res., 50, 125-137
DOI 10.1159/000486076
Publications 2017
Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study
Atherosclerosis, 266, 48-57
DOI 10.1016/j.atherosclerosis.2017.09.021
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus
Osteoporosis Int., 28 (1), 1-19
DOI 10.1007/s00198-016-3716-2
Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus
Cardiovasc. Diabetol., 16, 5
DOI 10.1186/s12933-016-0492-4
CXC chemokine ligand 16 is increased in gestational diabetes mellitus and preeclampsia and associated with lipoproteins in gestational diabetes mellitus at 5years follow-up
Diabetes Vasc. Dis. Res., 14 (6), 525-533
DOI 10.1177/1479164117728011
Large Reduction in Adiponectin During Pregnancy Is Associated With Large-for-Gestational-Age Newborns
J. Clin. Endocrinol. Metab., 102 (7), 2552-2559
DOI 10.1210/jc.2017-00289
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)
J. Bone Miner. Res., 32 (9), 1907-1914
DOI 10.1002/jbmr.3177
Estrogen Receptor alpha, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA
J. Clin. Endocrinol. Metab., 102 (9), 3581-3590
DOI 10.1210/jc.2017-00792
Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up
Endocrine, 57 (1), 35-45
DOI 10.1007/s12020-017-1314-5
The intriguing connections of leptin to hyperparathyroidism
Endocrine, 57 (3), 376-387
DOI 10.1007/s12020-017-1374-6
Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission
Psychoneuroendocrinology, 82, 117-125
DOI 10.1016/j.psyneuen.2017.05.010
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
Acta Oncol., 56 (4), 590-598
DOI 10.1080/0284186X.2016.1267870
A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours
Acta Neuropathol., 134 (4), 675-677
DOI 10.1007/s00401-017-1768-9
A rapid and sustained improvement of calcification propensity score (serum T-50) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
Clin. Transplant., 31 (12), e13131
DOI 10.1111/ctr.13131
Association of Circulating Wnt Antagonists With Severe Abdominal Aortic Calcification in Elderly Women
J. Endocr. Soc., 1 (1), 26-38
DOI 10.1210/js.2016-1040
Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1year after kidney transplantation
Clin. Transplant., 31 (1), e12869
DOI 10.1111/ctr.12869
Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study (Vol 14, 121, 2016)
J. Transl. Med., 15, 157
DOI 10.1186/s12967-017-1261-1
Publications 2016
LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors
J. Clin. Lipidol., 10 (6), 1369-1378
DOI 10.1016/j.jacl.2016.08.016
Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study
Eur. J. Endocrinol., 175 (2), 155-164
DOI 10.1530/EJE-16-0340
Human umbilical and fetal cerebral blood flow velocity waveforms following maternal glucose loading: a cross-sectional observational study
Acta Obstet. Gynecol. Scand., 95 (6), 683-689
DOI 10.1111/aogs.12913
Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly
Endocrine, 52 (2), 333-343
DOI 10.1007/s12020-015-0766-8
MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly
Endocrine, 53 (1), 327-330
DOI 10.1007/s12020-015-0816-2
Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response
Endocrine, 51 (2), 298-307
DOI 10.1007/s12020-015-0679-6
Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists
Endocrine, 53 (1), 313-321
DOI 10.1007/s12020-016-0903-z
Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
J. Renal Nutr., 26 (3), 196-203
DOI 10.1053/j.jrn.2015.11.007
Gene expression in term placentas is regulated more by spinal or epidural anesthesia than by late-onset preeclampsia or gestational diabetes mellitus
Sci Rep, 6, 29715
DOI 10.1038/srep29715
Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study
Cardiovasc. Diabetol., 15, 23
DOI 10.1186/s12933-016-0345-1
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly
Endocrine, 52 (3), 451-457
DOI 10.1007/s12020-015-0853-x
Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas
Mol. Cell. Endocrinol., 437 (C), 183-189
DOI 10.1016/j.mce.2016.08.030
The Impact of Adipose Tissue on Insulin Resistance in Acromegaly
Trends Endocrinol. Metab., 27 (4), 226-237
DOI 10.1016/j.tem.2016.02.005
The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment
Neuroendocrinology, 103 (3-4), 197-206
DOI 10.1159/000371818
Non-functioning pituitary adenomas: growth and aggressiveness
Endocrine, 53 (1), 28-34
DOI 10.1007/s12020-016-0940-7
Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study
J. Transl. Med., 14, 121
DOI 10.1186/s12967-016-0873-1
Publications 2015
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
Eur. J. Endocrinol., 173 (2), EG1-EG20
DOI 10.1530/EJE-15-0628
Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels
Diabetol. Metab. Syndr., 7, 69
DOI 10.1186/s13098-015-0066-8
A joined role of canopy and reversal cells in bone remodeling - Lessons from glucocorticoid-induced osteoporosis
Bone, 73, 16-23
DOI 10.1016/j.bone.2014.12.004
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol., 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057
Alternative splicing of placental lactogen (CSH2) in somatotroph pituitary adenomas
Neuroendocrinol. Lett., 36 (2), 136-142
beta-cell dysfunction in women with previous gestational diabetes is associated with visceral adipose tissue distribution
Eur. J. Endocrinol., 173 (1), 63-70
DOI 10.1530/EJE-15-0153
Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus
PLoS One, 10 (8), e0136892
DOI 10.1371/journal.pone.0136892
Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women
PLoS One, 10 (7), e0134266
DOI 10.1371/journal.pone.0134266
Effects of Parathyroidectomy Versus Observation on the Development of Vertebral Fractures in Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., 100 (4), 1359-1367
DOI 10.1210/jc.2014-3441
GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells
J. Endocrinol., 226 (1), 13-23
DOI 10.1530/JOE-15-0012
Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence
Eur. J. Endocrinol., 172 (6), R227-R239
DOI 10.1530/EJE-14-0883
Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease
BMC Endocr. Disord., 15, 62
DOI 10.1186/s12902-015-0055-9
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J. Cancer Surviv.-Res. Pract., 9 (4), 630-640
DOI 10.1007/s11764-015-0439-x
Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
Leuk. Lymphoma, 56 (12), 3306-3314
DOI 10.3109/10428194.2015.1036258
Increased Serum and Bone Matrix Levels of the Secreted Wnt Antagonist DKK-1 in Patients With Growth Hormone Deficiency in Response to Growth Hormone Treatment
J. Clin. Endocrinol. Metab., 100 (2), 736-743
DOI 10.1210/jc.2014-2912
Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
Transpl. Int., 28 (10), 1162-1171
DOI 10.1111/tri.12606
Publications 2014
Correlation between Absence of Bone Remodeling Compartment Canopies, Reversal Phase Arrest, and Deficient Bone Formation in Post-Menopausal Osteoporosis
Am. J. Pathol., 184 (4), 1142-1151
DOI 10.1016/j.ajpath.2013.12.005
Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial
Eur. J. Endocrinol., 171 (2), 229-235
DOI 10.1530/EJE-14-0249
Shape Information in Repeated Glucose Curves during Pregnancy Provided Significant Physiological Information for Neonatal Outcomes
PLoS One, 9 (3), e90798
DOI 10.1371/journal.pone.0090798
Seasonal variation in maternal and umbilical cord 25(OH) vitamin D and their associations with neonatal adiposity
Eur. J. Endocrinol., 170 (4), 609-617
DOI 10.1530/EJE-13-0842
Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures
Acta Neurochir., 156 (3), 441-449
DOI 10.1007/s00701-013-1959-7
Human fetoplacental and fetal liver blood flow after maternal glucose loading: a cross-sectional observational study
Acta Obstet. Gynecol. Scand., 93 (8), 778-785
DOI 10.1111/aogs.12419
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity
Orphanet J. Rare Dis., 9, 146
DOI 10.1186/s13023-014-0146-0
Celiac disease and risk of fracture in adults-a review
Osteoporosis Int., 25 (6), 1667-1676
DOI 10.1007/s00198-014-2683-8
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: Results from a 12-month prospective study
Growth Horm. IGF Res., 24 (1), 16-21
DOI 10.1016/j.ghir.2013.11.002
Elevated Osteoprotegerin Predicts Declining Renal Function in Elderly Women: A 10-Year Prospective Cohort Study
Am. J. Nephrol., 39 (1), 66-74
DOI 10.1159/000357787
Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., 99 (10), 3607-3618
DOI 10.1210/jc.2014-1417
Dual-Energy X-Ray Absorptiometry Is a Valid Method to Estimatimate Visceral Adipose Tissue in Adult Patients With Prader-Willi Syndrome During Treatment With Growth Hormone
J. Clin. Endocrinol. Metab., 99 (9), E1727-E1731
DOI 10.1210/jc.2014-2059
Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities
Eur. J. Endocrinol., 170 (1), 39-48
DOI 10.1530/EJE-13-0523
Pharmacokinetics, Pharmacodynamics, and Safety of Pasireotide LAR in Patients With Acromegaly: A Randomized, Multicenter, Open-Label, Phase I Study
J. Clin. Pharmacol., 54 (11), 1308-1317
DOI 10.1002/jcph.326
Maternal Factors Associated with Fetal Growth and Birthweight Are Independent Determinants of Placental Weight and Exhibit Differential Effects by Fetal Sex
PLoS One, 9 (2), e87303
DOI 10.1371/journal.pone.0087303
Publications 2013
Understanding Coupling between Bone Resorption and Formation Are Reversal Cells the Missing Link?
Am. J. Pathol., 183 (1), 235-246
DOI 10.1016/j.ajpath.2013.03.006
The important players in primary hyperparathyroidism
Clin. Endocrinol., 79 (6), 774-775
DOI 10.1111/cen.12291
Autosomal dominant osteopetrosis revisited: lessons from recent studies
Eur. J. Endocrinol., 169 (2), R39-R57
DOI 10.1530/EJE-13-0136
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
J. Clin. Endocrinol. Metab., 98 (11), E1730-E1739
DOI 10.1210/jc.2013-2145
Different levels of various glucocorticoid-regulated genes in corticotroph adenomas
Endocrine, 44 (1), 220-227
DOI 10.1007/s12020-012-9871-0
Newborn Body Fat: Associations with Maternal Metabolic State and Placental Size
PLoS One, 8 (2), e57467
DOI 10.1371/journal.pone.0057467
Adiposity-Related Inflammation: Effects of Pregnancy
Obesity, 21 (1), E124-E130
DOI 10.1002/oby.20120
Shape information from glucose curves: Functional data analysis compared with traditional summary measures
BMC Med. Res. Methodol., 13, 6
DOI 10.1186/1471-2288-13-6
Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates
Eur. J. Endocrinol., 168 (3), 371-378
DOI 10.1530/EJE-12-0531
Two Years of Growth Hormone Treatment in Adults With Prader-Willi Syndrome Do Not Improve the Low BMD
J. Clin. Endocrinol. Metab., 98 (4), E753-E760
DOI 10.1210/jc.2012-3378
Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery
PLoS One, 8 (6), e66927
DOI 10.1371/journal.pone.0066927
Epithelial Splicing Regulator Protein 1 and Alternative Splicing in Somatotroph Adenomas
Endocrinology, 154 (9), 3331-3343
DOI 10.1210/en.2013-1051
Thioredoxin Interacting Protein Is a Potential Regulator of Glucose and Energy Homeostasis in Endogenous Cushing's Syndrome
PLoS One, 8 (5), e64247
DOI 10.1371/journal.pone.0064247
Publications 2012
KIT protein expression and mutational status of KIT gene in pituitary adenomas
Virchows Arch., 460 (2), 171-181
DOI 10.1007/s00428-011-1185-8
Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
Clin. Endocrinol., 76 (1), 96-102
DOI 10.1111/j.1365-2265.2011.04163.x
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
Clin. Endocrinol., 77 (1), 72-78
DOI 10.1111/j.1365-2265.2011.04286.x
Premature Loss of Bone Remodeling Compartment Canopies Is Associated With Deficient Bone Formation: A Study of Healthy Individuals and Patients With Cushing's Syndrome
J. Bone Miner. Res., 27 (4), 770-780
DOI 10.1002/jbmr.1490
BONE Growth hormone replacement-implications for bone health
Nat. Rev. Endocrinol., 8 (6), 325-326
DOI 10.1038/nrendo.2012.50
The relation of psychological distress to salivary and serum cortisol levels in pregnant women shortly after the diagnosis of a structural fetal anomaly
Acta Obstet. Gynecol. Scand., 91 (1), 68-78
DOI 10.1111/j.1600-0412.2011.01266.x
Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
J. Clin. Endocrinol. Metab., 97 (8), E1506-E1514
DOI 10.1210/jc.2012-1760
TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover
Eur. J. Endocrinol., 166 (6), 1039-1048
DOI 10.1530/EJE-11-1082
Adipocytes as a Source of Increased Circulating Levels of Nicotinamide Phosphoribosyltransferase/Visfatin in Active Acromegaly
J. Clin. Endocrinol. Metab., 97 (4), 1355-1362
DOI 10.1210/jc.2011-2417
Fetal Growth versus Birthweight: The Role of Placenta versus Other Determinants
PLoS One, 7 (6), e39324
DOI 10.1371/journal.pone.0039324
A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation
Am. J. Transplant., 12 (12), 3316-3325
DOI 10.1111/j.1600-6143.2012.04233.x
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study
Endocrine, 41 (2), 191-199
DOI 10.1007/s12020-011-9560-4
AME Position Statement: Primary hyperparathyroidisrn in clinical practice
J. Endocrinol. Invest., 35 (7 S), 2-21
Publications 2011
Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism
Eur. J. Endocrinol., 165 (6), 851-864
DOI 10.1530/EJE-11-0589
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
Clin. Endocrinol., 74 (6), 736-743
DOI 10.1111/j.1365-2265.2011.03982.x
The importance of body composition and dry weight assessments in patients with chronic kidney disease (Review)
Acta Physiol. Hung., 98 (2), 105-116
DOI 10.1556/APhysiol.98.2011.2.2
Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours
Clin. Endocrinol., 75 (6), 811-818
DOI 10.1111/j.1365-2265.2011.04109.x
Disturbed energy metabolism after lung and heart transplantation
Clin. Transplant., 25 (2), E136-E143
DOI 10.1111/j.1399-0012.2010.01379.x
Correction of an unexpected increasing trend in glucose measurements during 7 years recruitment to a cohort study
Clin. Biochem., 44 (17-18), 1483-1486
DOI 10.1016/j.clinbiochem.2011.08.1150
Levels of Serotonin, Sclerostin, Bone Turnover Markers as well as Bone Density and Microarchitecture in Patients With High-Bone-Mass Phenotype Due to a Mutation in Lrp5
J. Bone Miner. Res., 26 (8), 1721-1728
DOI 10.1002/jbmr.376
Osteoclast Activity and Subtypes as a Function of Physiology and Pathology-Implications for Future Treatments of Osteoporosis
Endocr. Rev., 32 (1), 31-63
DOI 10.1210/er.2010-0006
Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
Eur. J. Endocrinol., 164 (2), 231-238
DOI 10.1530/EJE-10-0804
Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency
Growth Horm. IGF Res., 21 (2), 69-75
DOI 10.1016/j.ghir.2011.01.001
Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism
Clin. Endocrinol., 74 (2), 174-180
DOI 10.1111/j.1365-2265.2010.03909.x
Intra-operative MRI facilitates tumour resection during trans-sphenoidal surgery for pituitary adenomas
Acta Neurochir., 153 (7), 1367-1373
DOI 10.1007/s00701-011-1004-7
Vitamin D Treatment in Primary Hyperparathyroidism
Curr. Drug Saf., 6 (2), 100-107
DOI 10.2174/157488611795684613
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
Growth Horm. IGF Res., 21 (4), 185-190
DOI 10.1016/j.ghir.2011.05.002
Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
Clin. Endocrinol., 74 (1), 60-66
DOI 10.1111/j.1365-2265.2010.03884.x
Increased serum and bone matrix levels of transforming growth factor beta 1 in patients with GH deficiency in response to GH treatment
Eur. J. Endocrinol., 165 (3), 393-400
DOI 10.1530/EJE-11-0442
Publications 2010
Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study
Clin. Transplant., 24 (5), E145-E152
DOI 10.1111/j.1399-0012.2010.01231.x
HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas
Clin. Endocrinol., 73 (2), 229-235
DOI 10.1111/j.1365-2265.2010.03805.x
Dietary Vitamin K2 Supplement Improves Bone Status After Lung and Heart Transplantation
Transplantation, 89 (4), 458-464
DOI 10.1097/TP.0b013e3181c46b69
The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
J. Clin. Endocrinol. Metab., 95 (5), 2334-2342
DOI 10.1210/jc.2009-2197
The interleukins IL-6 and IL-1Ra: a mediating role in the associations between BMI and birth weight?
J. Dev. Orig. Health Dis., 1 (5), 310-318
DOI 10.1017/S204017441000036X
Assessing Body Composition in Healthy Newborn Infants: Reliability of Dual-Energy X-Ray Absorptiometry
J. Clin. Densitom., 13 (2), 151-160
DOI 10.1016/j.jocd.2010.01.121
Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
Eur. J. Endocrinol., 163 (5), 735-745
DOI 10.1530/EJE-10-0514
The Glucocorticoid-Induced Leucine Zipper Gene (GILZ) Expression Decreases after Successful Treatment of Patients with Endogenous Cushing's Syndrome and May Play a Role in Glucocorticoid-Induced Osteoporosis
J. Clin. Endocrinol. Metab., 95 (1), 246-255
DOI 10.1210/jc.2009-0595
Overweight is associated with impaired beta-cell function during pregnancy: a longitudinal study of 553 normal pregnancies
Eur. J. Endocrinol., 162 (1), 67-73
DOI 10.1530/EJE-09-0416
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome
Growth Horm. IGF Res., 20 (3), 179-184
DOI 10.1016/j.ghir.2009.12.004
One Year of Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition: Results from a Randomized, Placebo-Controlled Study
J. Clin. Endocrinol. Metab., 95 (11), 4943-4950
DOI 10.1210/jc.2010-0907
Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly
J. Clin. Endocrinol. Metab., 95 (1), 361-368
DOI 10.1210/jc.2009-0422
Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose
J. Matern.-Fetal Neonatal Med., 23 (1), 74-81
DOI 10.3109/14767050903121472
Hormonal alterations in adolescent chronic fatigue syndrome
Acta Paediatr., 99 (5), 770-773
DOI 10.1111/j.1651-2227.2010.01701.x
Publications 2009
New directions in pharmacological treatment of acromegaly
Expert Opin. Investig. Drugs, 18 (1), 13-22
DOI 10.1517/13543780802554357
Effect of Surgery on Cardiovascular Risk Factors in Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., 94 (7), 2255-2261
DOI 10.1210/jc.2008-2742
Spindle cell oncocytoma of the adenohypophysis: report of a case with marked cellular atypia and recurrence despite adjuvant treatment
Clin. Neuropathol., 28 (2), 91-95
Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death
Eur. J. Endocrinol., 160 (2), 233-237
DOI 10.1530/EJE-08-0550
Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry
J. Clin. Endocrinol. Metab., 94 (12), 4882-4890
DOI 10.1210/jc.2009-1368
Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7
Biochem. Biophys. Res. Commun., 378 (4), 804-809
DOI 10.1016/j.bbrc.2008.11.145
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
Cardiovasc. Diabetol., 8, 7
DOI 10.1186/1475-2840-8-7
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
Eur. J. Endocrinol., 161 (3), 451-458
DOI 10.1530/EJE-09-0421
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone
Eur. J. Endocrinol., 160 (6), 993-1002
DOI 10.1530/EJE-08-0880
Advances in osteoclast biology resulting from the study of osteopetrotic mutations
Hum. Genet., 124 (6), 561-577
DOI 10.1007/s00439-008-0583-8
Assessment of physical function in adults with Prader-Willi syndrome
Disabil. Rehabil., 31 (21), 1780-1784
DOI 10.1080/09638280902751980
A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women
Clin. Endocrinol., 71 (6), 828-833
DOI 10.1111/j.1365-2265.2009.03605.x
Publications 2008
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial
J. Clin. Endocrinol. Metab., 93 (8), 2984-2990
DOI 10.1210/jc.2008-0315
Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
Clin. Transplant., 22 (4), 462-468
DOI 10.1111/j.1399-0012.2008.00810.x
Low levels of Raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment
J. Clin. Endocrinol. Metab., 93 (4), 1211-1216
DOI 10.1210/jc.2007-2272
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma
Clin. Endocrinol., 68 (3), 458-465
DOI 10.1111/j.1365-2265.2007.03065.x
Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
J. Endocrinol. Invest., 31 (5), 400-405
DOI 10.1007/BF03346383
Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy
Scand. J. Clin. Lab. Invest., 68 (8), 759-766
DOI 10.1080/00365510802233442
Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies
Eur. J. Endocrinol., 159 (1), 49-54
DOI 10.1530/EJE-07-0682
Modifiable determinants of fetal macrosomia: role of lifestyle-related factors
Acta Obstet. Gynecol. Scand., 87 (4), 423-429
DOI 10.1080/00016340801989825
Publications 2007
Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: A prospective, randomized trial
J. Clin. Endocrinol. Metab., 92 (5), 1687-1692
DOI 10.1210/jc.2006-1836
Are nonresorbing osteoclasts sources of bone anabolic activity?
J. Bone Miner. Res., 22 (4), 487-494
DOI 10.1359/JBMR.070109
Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells
J. Bone Miner. Res., 22 (11), 1720-1731
DOI 10.1359/JBMR.070721
No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women
Bone, 40 (1), 175-181
DOI 10.1016/j.bone.2006.06.022
Autoimmune polyendocrine syndrome type 1 in Norway: Phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene
J. Clin. Endocrinol. Metab., 92 (2), 595-603
DOI 10.1210/jc.2006-1873
Publications 2006
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
Eur. J. Endocrinol., 154 (4), 537-543
DOI 10.1530/eje.1.02125
Degradation of the organic phase of bone by osteoclasts: A secondary role for lysosomal acidification
J. Bone Miner. Res., 21 (1), 58-66
DOI 10.1359/JBMR.050905
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
J. Am. Soc. Nephrol., 17 (6), 1746-1754
DOI 10.1681/ASN.2005121368
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study
Eur. J. Endocrinol., 154 (1), 109-118
DOI 10.1530/eje.1.02067
Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients
Eur. J. Endocrinol., 155 (5), 709-715
DOI 10.1530/eje.1.02285
Publications 2005
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
Eur. J. Endocrinol., 153 (3), 379-387
DOI 10.1530/eje.1.01971
LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women
Bone, 36 (4), 599-606
DOI 10.1016/j.bone.2005.01.006
Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study
Eur. J. Endocrinol., 153 (6), 887-894
DOI 10.1530/eje.1.02034
Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo
Am. J. Pathol., 167 (5), 1341-1348
DOI 10.1016/S0002-9440(10)61221-7
Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption
Am. J. Pathol., 166 (2), 467-476
DOI 10.1016/S0002-9440(10)62269-9
Bone metabolism and growth hormone deficiency - Experimental and clinical aspects
Front.Horm.Res., 33, 146-160
Publications 2004
Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women
Calcif. Tissue Int., 74 (1), 12-17
DOI 10.1007/s00223-002-0066-1
Physical activity and calcium consumption are important determinants of lower limb bone mass in older women
J. Bone Miner. Res., 19 (10), 1634-1639
DOI 10.1359/JBMR.040804
Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II
Am. J. Pathol., 164 (5), 1537-1545
DOI 10.1016/S0002-9440(10)63712-1
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
J. Am. Coll. Cardiol., 44 (10), 1970-1976
DOI 10.1016/j.jacc.2004.06.076
Publications 2003
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand. J. Gastroenterol., 38 (3), 320-327
DOI 10.1080/00365520310000681
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508
Serum levels of TGF-beta and fibronectin in autosomal dominant osteopetrosis in relation to underlying mutations and well-described murine counterparts
Crit. Rev. Eukaryot. Gene Expr., 13 (2-4), 163-171
Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: A cross-sectional study
J. Clin. Endocrinol. Metab., 88 (3), 1014-1018
DOI 10.1210/jc.2002-020977
Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: A longitudinal study
J. Clin. Endocrinol. Metab., 88 (4), 1492-1496
DOI 10.1210/jc.2002-021030
Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency-relationship with bone turn-over
Bone, 33 (4), 638-645
DOI 10.1016/S8756-3282(03)00240-0
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
Am. J. Hum. Genet., 72 (3), 763-771
DOI 10.1086/368277
Publications 2002
Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: Coincidence or causality?
J. Clin. Endocrinol. Metab., 87 (3), 1015-1016
DOI 10.1210/jc.87.3.1015
Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
Eur. J. Endocrinol., 146 (3), 389-395
DOI 10.1530/eje.0.1460389
Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: A double-blind, randomized, placebo-controlled study
J. Clin. Endocrinol. Metab., 87 (6), 2760-2763
DOI 10.1210/jc.87.6.2760
Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly
Eur. J. Clin. Invest., 32 (2), 122-128
DOI 10.1046/j.1365-2362.2002.00944.x
Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13
J. Bone Miner. Res., 17 (6), 1111-1117
DOI 10.1359/jbmr.2002.17.6.1111
Publications 2001
Mapping of autosomal dominant osteopetrosis type II (Albers-Schonberg disease) to chromosome 16p13.3
Am. J. Hum. Genet., 69 (3), 647-654
DOI 10.1086/323132
Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the CICN7chloride channel gene
Hum. Mol. Genet., 10 (25), 2861-2867
DOI 10.1093/hmg/10.25.2861
Leptin response to endogenous acute stress is independent of pituitary function
Eur. J. Endocrinol., 145 (3), 295-301
DOI 10.1530/eje.0.1450295
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess - possible role in bone homeostasis
Eur. J. Endocrinol., 145 (6), 685-690
DOI 10.1530/eje.0.1450685
Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency
Eur. J. Clin. Invest., 31 (1), 72-78
DOI 10.1046/j.1365-2362.2001.00768.x
Publications 2000
Serum creatine kinase isoenzyme BB in mammalian osteopetrosis
Clin. Orthop. Rel. Res. (377), 241-247
Leptin revels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index
J. Endocrinol. Invest., 23 (6), 349-355
DOI 10.1007/BF03343737
Publications 1999
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
J. Clin. Endocrinol. Metab., 84 (1), 145-150
DOI 10.1210/jc.84.1.145
Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome
Eur. J. Endocrinol., 141 (2), 126-131
DOI 10.1530/eje.0.1410126
Increased cortical bone content of insulin-like growth factors in acromegalic patients
J. Clin. Endocrinol. Metab., 84 (1), 123-127
DOI 10.1210/jc.84.1.123
Publications 1998
Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine
Eur. J. Endocrinol., 139 (1), 29-35
DOI 10.1530/eje.0.1390029
Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men
Bone, 23 (3), 297-302
DOI 10.1016/S8756-3282(98)00097-0
Publications 1997
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p21
Am. J. Hum. Genet., 61 (2), 363-369
DOI 10.1086/514844
Publications 1996
Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency
Eur. J. Endocrinol., 135 (6), 666-671
DOI 10.1530/eje.0.1350666
Cortical bone remodeling in autosomal dominant osteopetrosis: A study of two different phenotypes
Bone, 18 (1), 67-72
DOI 10.1016/8756-3282(95)00424-6
Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males
Bone, 18 (6), 539-544
DOI 10.1016/8756-3282(96)00074-9
Publications 1995
COLLAGEN-METABOLISM IN 2 TYPES OF AUTOSOMAL-DOMINANT OSTEOPETROSIS DURING STIMULATION WITH THYROID-HORMONES
Eur. J. Endocrinol., 133 (5), 557-563
DOI 10.1530/eje.0.1330557
BIOLOGICAL VARIATION OF SERUM AND URINARY MAGNESIUM IN APPARENTLY HEALTHY-MALES
Scand. J. Clin. Lab. Invest., 55 (6), 549-558
DOI 10.3109/00365519509075394
AUTOSOMAL-DOMINANT OSTEOPETROSIS - BONE-MINERAL MEASUREMENTS OF THE ENTIRE SKELETON OF ADULTS IN 2 DIFFERENT SUBTYPES
Bone, 16 (4), 431-434
Publications 1994
BIOCHEMICAL MARKERS USED IN THE DIAGNOSIS AND MONITORING OF OSTEOPOROSIS
Scand. J. Clin. Lab. Invest., 54 219, 33-35
DOI 10.3109/00365519409088574
BODY-COMPOSITION IN ACTIVE ACROMEGALY DURING TREATMENT WITH OCTREOTIDE - A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSS-OVER STUDY
Clin. Endocrinol., 41 (3), 323-329
DOI 10.1111/j.1365-2265.1994.tb02552.x